Table.
Arterial Remodeling: Impact of Dietary Sodium, Aging, Hypertension, and Atherosclerosis and Ang II Signaling
Aging | |||||||
---|---|---|---|---|---|---|---|
Humans (>65 yrs) |
Monkeys (15–20 yrs) |
Rats (24–30 mos) |
Rabbits (3–6 yrs) |
Hypertension | Atherosclerosis | Ang II Signaling | |
Lumenal dilation | + | + | + | + | ? | ? | ? |
↑ Stiffness | + | + | + | + | + | + | + |
Endothelial dysfunction | + | + | + | + | + | + | + |
Diffuse Intimal Thickening | + | + | + | + | + | + | + |
Lipid involvement | − | − | − | − | ± | + | + |
↑ VSMC number | + | + | + | + | + | + | + |
Macrophages | + | − | − | + | + | + | + |
↑ Matrix | + | + | + | + | + | + | + |
↑ Local ACE-ANGII- AT1 | + | + | + | + | + | + | + |
MMP/Calpain dysregulation | + | + | + | ? | + | + | + |
↑ MCP-1/CCR2 | + | + | + | + | + | + | + |
↑ ICAM-1 | ? | ? | + | ? | + | + | + |
↑ TGF-B | + | + | + | ? | + | + | + |
↑ NADPH Oxidase | ? | ? | + | ? | + | + | + |
↓ Nitric Oxide Bioavailability | ? | ? | + | + | + | + | + |
HYPERTENSION | ± | ± | ± | ? | + | ± | + |
ATHEROSCLEROSIS | ± | − | − | − | ± | + | + |
? =information unknown